Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01453
|
|||||
| Drug Name |
SJG-136
|
|||||
| Synonyms |
SG-2000; SJG-136; SP-2001
|
|||||
| Indication | Recurrent fallopian tube cancer [ICD11: 2C74] | Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C31H32N4O6
|
|||||
| Canonical SMILES |
COC1=C(C=C2C(=C1)C(=O)N3CC(=C)CC3C=N2)OCCCOC4=C(C=C5C(=C4)N=CC6CC(=C)CN6C5=O)OC
|
|||||
| InChI |
InChI=1S/C31H32N4O6/c1-18-8-20-14-32-24-12-28(26(38-3)10-22(24)30(36)34(20)16-18)40-6-5-7-41-29-13-25-23(11-27(29)39-4)31(37)35-17-19(2)9-21(35)15-33-25/h10-15,20-21H,1-2,5-9,16-17H2,3-4H3/t20-,21-/m0/s1
|
|||||
| InChIKey |
RWZVMMQNDHPRQD-SFTDATJTSA-N
|
|||||
| CAS Number |
CAS 232931-57-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 556.6 | Topological Polar Surface Area | 102 | ||
| Heavy Atom Count | 41 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
1.9
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01200797) SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin | |||||
| 2 | Optimization of the antitumor activity of sequence-specific pyrrolobenzodiazepine derivatives based on their affinity for ABC transporters. AAPS J. 2010 Dec;12(4):617-27. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.